Class information for:
Level 1: ACCELERATED BLOOD CLEARANCE ABC PHENOMENON//ANTI PEG IGM//ABC PHENOMENON

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
23579 286 38.8 77%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
520 14322 SOLID LIPID NANOPARTICLES//NANOSTRUCTURED LIPID CARRIERS//NANOSUSPENSION

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ACCELERATED BLOOD CLEARANCE ABC PHENOMENON Author keyword 45 90% 7% 19
2 ANTI PEG IGM Author keyword 42 94% 5% 15
3 ABC PHENOMENON Author keyword 24 91% 3% 10
4 ACCELERATED BLOOD CLEARANCE Author keyword 21 78% 5% 14
5 SUB BIOPHARMACEUT SCI Address 15 46% 8% 24
6 NANOMED EDUC Address 11 69% 3% 9
7 REPEATED INJECTION Author keyword 10 63% 3% 10
8 PHARMACOKINET BIOPHARMACEUT Address 9 21% 13% 37
9 ACCELERATED BLOOD CLEARANCE PHENOMENON Author keyword 7 64% 2% 7
10 VACCINE PROD DELIVERY Address 5 60% 2% 6

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ACCELERATED BLOOD CLEARANCE ABC PHENOMENON 45 90% 7% 19 Search ACCELERATED+BLOOD+CLEARANCE+ABC+PHENOMENON Search ACCELERATED+BLOOD+CLEARANCE+ABC+PHENOMENON
2 ANTI PEG IGM 42 94% 5% 15 Search ANTI+PEG+IGM Search ANTI+PEG+IGM
3 ABC PHENOMENON 24 91% 3% 10 Search ABC+PHENOMENON Search ABC+PHENOMENON
4 ACCELERATED BLOOD CLEARANCE 21 78% 5% 14 Search ACCELERATED+BLOOD+CLEARANCE Search ACCELERATED+BLOOD+CLEARANCE
5 REPEATED INJECTION 10 63% 3% 10 Search REPEATED+INJECTION Search REPEATED+INJECTION
6 ACCELERATED BLOOD CLEARANCE PHENOMENON 7 64% 2% 7 Search ACCELERATED+BLOOD+CLEARANCE+PHENOMENON Search ACCELERATED+BLOOD+CLEARANCE+PHENOMENON
7 CARPA 5 63% 2% 5 Search CARPA Search CARPA
8 ANTIBODIES TO PHOSPHOLIPIDS 4 67% 1% 4 Search ANTIBODIES+TO+PHOSPHOLIPIDS Search ANTIBODIES+TO+PHOSPHOLIPIDS
9 ACCELERATED BLOOD CLEARANCE ABC 3 100% 1% 3 Search ACCELERATED+BLOOD+CLEARANCE+ABC Search ACCELERATED+BLOOD+CLEARANCE+ABC
10 ANTIBODIES TO CHOLESTEROL 3 100% 1% 3 Search ANTIBODIES+TO+CHOLESTEROL Search ANTIBODIES+TO+CHOLESTEROL

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ABC PHENOMENON 21 78% 5% 14
2 REPEATED INJECTION 19 68% 6% 17
3 ACCELERATED BLOOD CLEARANCE 19 33% 16% 47
4 REPEATED INJECTIONS 12 32% 11% 31
5 PEGYLATED LIPOSOMES 7 17% 13% 37
6 LACTOSOME 6 80% 1% 4
7 ALTERNATIVE PATHWAY TURNOVER 4 50% 2% 6
8 ANTI CHOLESTEROL ANTIBODIES 4 56% 2% 5
9 GLYCOL MODIFIED PROTEINS 3 37% 2% 7
10 POLYETHYLENE GLYCOL LIPOSOMES 2 24% 3% 8

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
The Immunogenicity of Polyethylene Glycol: Facts and Fiction 2013 37 24 67%
The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage 2013 34 85 53%
Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics 2014 7 61 49%
Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention 2011 69 76 24%
Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes 2008 114 57 25%
Material properties in complement activation 2011 40 75 23%
Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective 2012 90 107 11%
A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines 2012 12 54 41%
Questioning the use of PEGylation for drug delivery 2013 4 53 45%
Cancer nanomedicine and the complement system activation paradigm: Anaphylaxis and tumour growth 2014 4 35 26%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SUB BIOPHARMACEUT SCI 15 46% 8.4% 24
2 NANOMED EDUC 11 69% 3.1% 9
3 PHARMACOKINET BIOPHARMACEUT 9 21% 13% 37
4 VACCINE PROD DELIVERY 5 60% 2.1% 6
5 MOL TARGETING POLYMER TOXICOL GRP 3 22% 3.8% 11
6 PHARMACEUT NANOTECHNOL NANOTOXICOL 3 22% 3.8% 11
7 NANOBIOTECHNOL REGENERAT MED 2 40% 1.4% 4
8 ADJUVANT ANTIGEN 1 21% 1.4% 4
9 NANOMED GRP 1 20% 1.4% 4
10 ASSIUT INT NANOMED 1 50% 0.3% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000186372 LIPOSOME//THERMOSENSITIVE LIPOSOMES//IMMUNOLIPOSOMES
2 0.0000143051 LIPID NANOCAPSULES//U1066//U646
3 0.0000109042 FUSOGENIC LIPIDS//DRUG DELIVERY SYST DEV//B30 MDP
4 0.0000088015 PROTEIN CORONA//BIONANO INTERACT//BIO NANO INTERFACE
5 0.0000081871 LIPOSOME IMMUNOASSAY//LIPOSOME IMMUNE LYSIS ASSAY//CAPILLARY MIGRATION
6 0.0000076630 PLATELET SUBSTITUTE//ORG EUROPEAN STUDIES//TWINSSHINJUKU KU
7 0.0000073103 PEPTIDE SELF ASSEMBLED MONOLAYERS//HELICAL PEPTIDE//HELIX PEPTIDE
8 0.0000067759 PEGYLATION//MONOMETHOXYPOLYETHYLENE GLYCOL//BRANCHED PEG
9 0.0000064806 TL 2 RESPONSE//ADCC REACTION//ANTI IG DEXTRAN
10 0.0000057572 NANOCAPSULES//LIPID CORE NANOCAPSULES//POLYALKYLCYANOACRYLATE